Reports that the U.S. National Institutes of Health and WiCell Research Institute has signed a memorandum of understanding that provides the government agency with access to established embryonic stem cell lines for a nominal processing fee. Royalty-free sublicense to relevant intellectual property rights; Cell-based therapies.